Bumper Offer - Urjas oil Just @ Rs. 1
Vogs M 0.3 Tablet SR is a prescription medicine that is available as a Tablet. Vogs M 0.3 Tablet SR also has some secondary and off-label uses. These are listed below.
The correct dosage of Vogs M 0.3 Tablet SR depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Vogs M 0.3 Tablet SR include Weakness, Headache, Nausea or vomiting. While these are the most often observed Vogs M 0.3 Tablet SR side effects, there are can be others also. These have been listed below. These side effects of Vogs M 0.3 Tablet SR are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Vogs M 0.3 Tablet SR is Severe for pregnant women and Severe for women who are breastfeeding. Warnings related to Vogs M 0.3 Tablet SR's effects on the liver, heart and kidney, if any, have been listed below.
Vogs M 0.3 Tablet SR can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Vogs M 0.3 Tablet SR in conditions like Diabetic Ketoacidosis.
Drug reaction of Vogs M 0.3 Tablet SR with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Vogs M 0.3 Tablet SR is not safe while driving, and is is not addictive in nature.
Vogs M 0.3 Tablet SR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Vogs M 0.3 Tablet SR is used -
Severe
Moderate
Common
Is the use of Vogs M 0.3 Tablet SR safe for pregnant women?
Vogs M can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Vogs M 0.3 Tablet SR safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Vogs M. It should only be taken after medical advice.
What is the effect of Vogs M 0.3 Tablet SR on the Kidneys?
There can be some harmful effects on your kidneys after taking Vogs M. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Vogs M 0.3 Tablet SR on the Liver?
Vogs M can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Vogs M 0.3 Tablet SR on the Heart?
Vogs M may have mild side effects on the heart. Most people will never see any effect on the heart.
Vogs M 0.3 Tablet SR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Vogs M 0.3 Tablet SR unless your doctor advises you to do so -
Is this Vogs M 0.3 Tablet SR habit forming or addictive?
No, there is no any evidence that Vogs M 0.3 Tablet SR is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Vogs M 0.3 Tablet SR. So it is best to avoid driving.
Is it safe?
Yes, Vogs M 0.3 Tablet SR is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Vogs M 0.3 Tablet SR for mental disorders.
Interaction between Food and Vogs M 0.3 Tablet SR
There isn't any research available on the side effects of taking Vogs M 0.3 Tablet SR with food.
Interaction between Alcohol and Vogs M 0.3 Tablet SR
No research has been done on this till date. Therefore, it is not known what the effect of taking Vogs M 0.3 Tablet SR with alcohol will be.
Vogs M contain voglibose. It works by inhibiting the enzyme (alpha-glucosidase) that reduces the rate of digestion of complex carbohydrates. Less glucose is absorbed because the carbohydrates are not broken down into glucose molecules. Hence in this way, Vogs M reduces blood sugar levels.
No, Vogs M does not cause weight loss. It has not been reported by a patient who is taking this medicine. However, if you experience weight loss after taking this drug then it might be due to some other reason.
Take Vogs M as advised by your doctor. It can be taken orally three times daily immediately before each meal. Precautions must be taken in patients with improper liver or kidney function.
Yes, Vogs M can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with voglibose. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia. It is best to consult your doctor if you feel any unwanted effects.
Vogs M itself does not cause alopecia ( hair loss). However, the conditions treated by Vogs M, type 2 diabetes and PCOS, often list hair loss as a possible symptom.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
